Chandra Ganjoo

Chandra Ganjoo

Active Director Director DIN 07337352
DIN 07337352 First appointment Jan 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Jan 2016
Shareholding value •••• Premium profile

About Chandra Ganjoo

Data last updated:

Chandra Ganjoo is a Director at Trivitron Healthcare Private Limited (since 2016), Director at Biosystems Diagnostics Private Limited (since 2021) and Additional Director at Aloka Trivitron Medical Technologies Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Healthcare and Artificial Intelligence. The 4 current companies with reported revenue have a combined latest revenue of ₹604 Cr; the largest is Trivitron Healthcare Private Limited at ₹497 Cr (FY 2024).

DIN 07337352
Primary Designation Director
Industry Healthcare
First Appointment 20 Jan 2016
Oldest Company Age 28 yrs
Largest company Trivitron Healthcare Private Limited · ₹497 Cr (FY 2024)
Combined revenue ₹604 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trivitron Healthcare Private Limited U85110TN1998PTC040515
Director20 Jan 20161998₹497 Cr (FY 2024)Active
Director10 Feb 20212003₹103 Cr (FY 2025)Active
Additional Director06 Mar 20252007₹3.20 Cr (FY 2025)Active
Hexel Technologies Private Limited U74999TN2016PTC111700
Director24 Feb 20212016₹90 Lakh (FY 2022)Active
Director16 Feb 20262026Active
Director03 Sep 20252025Active

Directorship timeline

Open interactive timeline →
Biosystems Diagnostics Private Limited
Hexel Technologies Private Limited
Trivitron Healthcare Private Limited
Trivitron Digital & Ai Solutions Private Limited
Premium access

Shareholding and investment profile for Chandra Ganjoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Ganjoo

Chandra Ganjoo currently holds 6 directorships: Trivitron Healthcare Private Limited (Director, since 20 Jan 2016, revenue ₹497 Cr (FY 2024)); Biosystems Diagnostics Private Limited (Director, since 10 Feb 2021, revenue ₹103 Cr (FY 2025)); Aloka Trivitron Medical Technologies Private Limited (Additional Director, since 06 Mar 2025, revenue ₹3.20 Cr (FY 2025)); Hexel Technologies Private Limited (Director, since 24 Feb 2021, revenue ₹90 Lakh (FY 2022)); Mylab Trivitron Next Gen Technologies Private Limited (Director, since 16 Feb 2026); and 1 more.

Chandra Ganjoo was first appointed on 20 Jan 2016 as Director at Trivitron Healthcare Private Limited. The most recent appointment on record is 16 Feb 2026 at Mylab Trivitron Next Gen Technologies Private Limited.

The 4 current companies of Chandra Ganjoo that report revenue have a combined latest revenue of ₹604 Cr: Trivitron Healthcare Private Limited ₹497 Cr (FY 2024); Biosystems Diagnostics Private Limited ₹103 Cr (FY 2025); Aloka Trivitron Medical Technologies Private Limited ₹3.20 Cr (FY 2025); Hexel Technologies Private Limited ₹90 Lakh (FY 2022).

The current boards of Chandra Ganjoo's companies include Athmanathan Ganesan (Trivitron Healthcare Private Limited), Gomathy Babu Sadacharam Kulandaivelu (Trivitron Healthcare Private Limited), Kavya K Velu (Trivitron Healthcare Private Limited), Navjot Singh Vig (Trivitron Healthcare Private Limited), Antonio Elduque Terron (Biosystems Diagnostics Private Limited), Kalyanaraman Thiyagarajan (Biosystems Diagnostics Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available